84
Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric Ethics 34 th Annual Perinatal Symposium Advocate Christ Medical Center Hope Children’s Hospital November 17-18, 2010 Oak Lawn, Illinois

Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Embed Size (px)

Citation preview

Page 1: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Recent Advances in Neonatology

Jonathan Fanaroff, MD, JDAssistant Professor of PediatricsCase School of Medicine

DirectorRainbow Center for Pediatric EthicsRainbow Babies & Children's HospitalCleveland, Ohio

34th Annual Perinatal SymposiumAdvocate Christ Medical CenterHope Children’s HospitalNovember 17-18, 2010Oak Lawn, Illinois

Page 2: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

I have no conflicts of interest to disclose

I will not be discussing off label uses of any drugs or devices

All pictures were obtained from public sources

Page 3: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric
Page 4: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

NEONATAL REPORT CARD

• Prevent prematurity – MINIMAL PROGRESS• Reduce asphyxia - HYPOTHERMIA

EFFECTIVE BUT ADJUNCTIVE RX NEEDED• Eliminate GBS and nosocomial infections – GBS

reduced; nosocomial infections – PROGRESS.• Reduce NEC – PROBIOTICS?• Prevent barotrauma- BPD- CPAP >

SURFACTANT/MECHANICAL VENTILATION• Prevent retinopathy - LOWER OXYGEN

SATURATION?• Avoid iatrogenesis/medication errors- HIGH

PRIORITY- STILL TOO MANY MISTAKES

Page 5: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Courtesy of Linda deVries

Page 6: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric
Page 7: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

FETAL TREATMENTESTABLISHED

• Twin-twin transfusion• CCAM with hydrops• Sacrococcygeal teratoma• Posterior Urethral Valves• Fetal arrhythmias• Airway compromise

Page 8: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

FETAL TREATMENT FUTURE

• Stem cell transplantation• Gene therapy• Correction of birth defects• Wound healing without scars

Page 9: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

BENEFITS OF DELAYED CORD CLAMPING IN PRETERM INFANTS

• Increased blood volume• Improved circulatory and

respiratory function including higher BP

• Improved cerebral oxygenation• Reduced intraventricular

hemorrhage• Increased urine output

Page 10: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

BENEFITS OF DELAYED CORD CLAMPING IN PRETERM INFANTS

• Higher hematocrit• Acquisition of progenitor cells- this facilitates

red blood cell production and enhances the immune system

• Reduced need for blood transfusions• Reduced NEC• Reduced Late Onset Sepsis

Page 11: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

HARM OF DELAYED CORD CLAMPING IN PRETERM INFANTS

• No adverse effects of delayed cord clamping for preterm infants have been identified except higher peak serum bilirubin concentration (Reynolds, 2008). 

• Delayed cord clamping does not effect survival of preterm infants (Rabe et al, 2004; Rabe et al, 2008). 

• There has been only one report examining the impact of delayed cord clamping on neurodevelopmental outcome (Mercer et al, 2010).  The investigators found evidence of improved motor scores at 7 months corrected age in preterm infants who had received delayed cord clamping at birth.

Page 12: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

DELAYED CORD CLAMPING

• Despite knowledge since the 1960s that delayed clamping of the umbilical cord increases the volume of placental transfusion in both term and preterm infants and continued studies which show benefits and little, if any, risk in preterm infants, it has not gained wide acceptance 

Page 13: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Baby girl, Twin B, 24 weeks GA, BW 585 g, No ANS; Vaginal delivery; 2 days old, RDS;MECHANICAL VENTILATION;Grade I IVH, BRUISED,hyperbilirubinemia, phototherapy

PREVENT PREMATURITY

Page 14: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

PREMATURITY

• The frequency of preterm births is about 12-13% in the USA and 5-9% in many other developed countries;

• The rate of preterm birth has increased in many locations, predominantly because of increasing indicated preterm births and preterm delivery of artificially conceived multiple pregnancies.

• Common reasons for indicated preterm births include pre-eclampsia or eclampsia, and intrauterine growth restriction.

Page 15: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

HOT TOPICS • PREVENTING/REDUCING LATE PRETERM BIRTHS• Late Preterm infants represent almost three-

fourths of all premature births in the United States.

• The identification of late preterm infants as a high-risk group of infants has been an important public health breakthrough.

• Before the recognition that late preterm infants have unique physiology and risks, they constituted a relative 'silent morbidity and mortality'

Page 16: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

LATE PRETERM BIRTH : PREVENTION

OSHIRO – Concerted system and multidisciplinary team effort changed culture and reduced deliveries before

39 weeks from 28% to 3%OHIO PERINATAL COLLABORATIVE

Document G.A. and reason for delivery= RESULTED IN INDUCTIONS WITHOUT

INDICATIONS DECREASING FROM 13%-8%

Page 17: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

PREMATURITY –FACTORS AFFECTING SURVIVAL

• Approach to and changing borders of viability? Importance of– Birth weight; – gestational age– gender– antenatal steroids– site and time of delivery – mode of delivery

Born at home at 25 weeks gestation. Male,600g, Temp. 33oC on arrival in peripheral hospital. .

Page 18: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

SURVIVAL -NICHD -NRN 1998 – 2003 (n = 4165) JAPAN and LITERATURE

GA SURVIVAL JAPAN DANI

22 wk 5 % 40 % 2%

23 wk 26 % 60 % 13%

24 wk 56 % 80 % 35%

25 wk 76 % 85 % 56%

• Tyson 2008; Itabashi 2009 Dani 2009

Page 19: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Copyright ©2010 American Academy of Pediatrics

Stoll, B. J. et al. Pediatrics 2010;126:443-456

FIGURE 1 Survival to discharge according to GA among 9575 VLBW infants born in NICHD NRN centers between January 1, 2003, and December 31, 2007

Page 20: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

NICHD Neonatal Network 1998 – 2003 (n = 4165)

GA survival NDI survival w/o NDI

22 wk 5 % 80 % 1 %

23 wk 26 % 65 % 9 %

24 wk 56 % 50 % 28 %

25 wk 76 % 39 % 46 %

Page 21: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

THE MYTH OF OXYGEN

200 years after its discovery we do not know • The optimal oxygen concentration or oxygen

saturation during resuscitation of the newly born.

• The optimal oxygen saturation in treating extremely low birth weight infants.

• Short and long term effects on morbidity and mortality, growth and development of using oxygen in the newborn period.

Page 22: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

How much Oxygen is needed?• What is the evidence to lower initial FiO2 ?

– Clinical data have demonstrated that pure oxygen:• Increases neonatal mortality (~ 40%, also in developed

countries).• Increases oxidative stress at least 4 weeks after birth.• Increases myocardial and kidney injury.• Delays recovery (significantly lower 5 min Apgar score

and heart rate; prolonged time to first breath and first cry)

• Increases time of resuscitation needed and oxygen.• Is associated with higher risk of childhood leukemia

and cancer.(Saugstad OD, Ramji S, Vento M. Pediatrics 2006; )

Page 23: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

01

02

03

04

05

06

07

08

09

01

00O

xyge

n sa

tura

tion

(%)

1 2 3 4 5 6 7 8 9 10minutes from birth

10-90th centile median

Term Neonates > 37 weeks gestation

Dawson Ja et al Pediatrics 2010

Page 24: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

01

02

03

04

05

06

07

08

09

01

00O

xyge

n sa

tura

tion

(%)

1 2 3 4 5 6 7 8 9 10minutes from birth

10-90th centile median

Preterm < 37 weeks gestation

Dawson Ja et al Pediatrics 2010

Page 25: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

0

200

400

600

800

1000

ml O2 / kg

Oxygen load in ELBW infants resuscitated initially with 30% or 90% FiO2.

Lox group Hox group

Lox group 465

Hox group 864

1

Escrig R et al Pediatrics 2008

Page 26: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Copyright ©2010 American Academy of Pediatrics

Kattwinkel, J. et al. Pediatrics 2010;126:e1400-e1413

2010 AHA Neonatal Resuscitation Guidelines

Page 27: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric
Page 28: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric
Page 29: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Pulse Ox in the Delivery Room

• Use when resuscitation can be anticipated• Use when PPV is given for more than a

few breaths• Use when cyanosis is persistent• Use when supplementary oxygen is

administered• Measure preductal sat (Right UE)

Page 30: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Oxygen in the Delivery Room

• Can start with room air or blended O2

• Goal is an oxygen saturation value in the interquartile range of preductal sats in healthy term babies born via vaginal delivery at sea level

• If blended oxygen is not available, resuscitation should be initiated with room air

Page 31: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

1930’s-1950’s: Oxygen Rx, no Mechanical Ventilation

Page 32: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

“We have no proof that the regular type of respiration, which we are accustomed to consider “normal,” is better for a premature infant than the periodic type of breathing described. Likewise, we have no convincing evidence that an increased oxygen content of arterial blood is beneficial or necessarily of importance. It is evident, however, that these healthy premature infants breathed in a more normal manner in an oxygen-enriched atmosphere.”

Wilson JL et al. Am J Dis Child 1942;63:1080-5

Page 33: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Oxygen & RLF

Singleton RLF

Mutliples RLF

Singleton Scarring

RLF

Multiples Scarring

RLF

0

10

20

30

40

50

60

70

80

90

70

83

17

67

31

42

5

14

Routine OxygenCurtailed Oxygen

Page 34: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Deaths on day of birth /1000 live births

Mortality on the first day of life in the United States and in England and Wales before (open circles and squares) and after (closed circles and squares) oxygen restriction. (Redrawn from Bolton and Cross, 1974).

Page 35: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

History of Perinatology

1940 -

1960

Respiratory distress

Blindness from ROP

Liberal O2

Restricted O2

ROP

Death & CP

Year Problem Treatment Iatroepidemic

Page 36: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Bill Silverman

Teach thy tongue to say I do not know and thou shalt progress.

Page 37: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

SUPPORT Trial

SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010;362:1959-1969

Page 38: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

PRIMARY OUTCOME

Lower Saturation

GroupN=654

Higher Saturation

GroupN=662

Adjusted Relative Risk

(95% CI)

Severe ROP/death 28.3% 32.1% 0.90 (0.76,

1.06)Severe ROP 8.6% 17.9% 0.52 (0.37,

0.73) NNT=11

Death 19.9% 16.2% 1.27 (1.01, 1.60) NNH=27

Carlo NICHD- Support Trial NEJM 2010

Page 39: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Feasibility of Automated Regulation ofInspired O2 in Ventilated Preterm Infants

Perc

en

t of

Tim

e

O2 Saturation (SpO2)

Claure, (Pediatrics)

*

*p<0.02

*

0

10

20

30

40

50

60

88-95% >95%

Automated Routine

Page 40: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric
Page 41: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric
Page 42: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

GBS

• Recommendations for universal screening were rapidly adopted and GBS disease has declined.

• Improved management of preterm deliveries and improved collection, processing, and reporting of culture results may prevent additional cases of early-onset group B streptococcal disease.

Page 43: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

GBS GUIDELINES 2010still in final reviews

• GBS remains the leading cause of EOS• Antenatal GBS screening and intrapartum

antibiotic prophylaxis (IAP) for culture- +ve and high risk remain foundation

• ? New features address preterm labor, mothers with penicillin allergy and culture techniques.

Page 44: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Advances in Nutrition

Denne and P

oindexter, Sem

Perinatol 2007

Page 45: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Protein Intake for VLBW Infants• TPN – usually 3.5 g/kg/d. Closer to 3.0

g/kg/d at term.• Up to 4.0 g/kg/d in some very small

infants.• Provide 2 – 3 g/kg/d from birth when

possible,• advance to full protein in 3-4 days.• Monitor BUN (what is too high/low?), little

benefit to monitoring albumin/pre-albumin

S. Abrams, MD

Page 46: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

PROBIOTICS• Probiotics investigated

extensively but not in the USA• No approved product• Debate on best bacilli, dose,

duration of therapy, • Potential risks?-sepsis;allergy

Page 47: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Preventive Probiotic Trials in Preterm Infants

Study Hoyos 1999

Dani 2002

Lin 2005

Bin-Nun 2005

Lin 2008

Samanta 2008

Probiotic species

L. acidophilus B. infantis (Infloran®)

L. GG L. acidophilus B. infantis (Infloran®)

ABCdophilus® S. Thermophilus

B. infantis

B. bifidum

L. Acidophilus B. bifidum (Infloran®)

B. Infantis B. bifidum B. longum L. acidophilus

Effect Decreased NEC vs historic controls

1.4% vs 2.7%, NS

1.1% vs 5.3%, p < 0.05

1% vs 14%, p < 0.05

1.8% vs 6.5%, p = 0.02

5.5% vs 15.8%, p = 0.04

Probiotics: 53/2093 (2.5%) vs Control: 142/2143 (6.6%) p<0.01, NNT=24

Page 48: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Copyright ©2010 American Academy of Pediatrics

Deshpande, G. et al. Pediatrics 2010;125:921-930

FIGURE 2 Effect of probiotics on NEC

Page 49: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Copyright ©2010 American Academy of Pediatrics

Deshpande, G. et al. Pediatrics 2010;125:921-930

FIGURE 3 Effect of probiotics on blood culture-positive sepsis

Page 50: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Copyright ©2010 American Academy of Pediatrics

Deshpande, G. et al. Pediatrics 2010;125:921-930

FIGURE 4 Effect of probiotics on all-cause mortality

Page 51: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

DESHPANDE ET AL

• The results of our update confirm those of the previous systematic reviews while improving their precision and further reducing the role of chance alone.

• The dramatic benefits in terms of reduced risk for all-cause mortality and definite NEC are sustained; however, despite the addition of 4 new trials (N = 783) to the existing data, there is still no evidence that probiotic supplementation reduces the risk for LATE ONSET SEPSIS.

Page 52: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

• Ten different probiotics used in 11 studies• None of the studies were done in the U.S.• No FDA approved probiotics for preemies• Quality control in manufacturing a concern• We don’t know which products in which

population of at-risk neonates

Page 53: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

S. Abrams, MD

Page 54: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

LACTOFERRIN

• Lactoferrin, an iron-binding protein with multiple physiological functions –anti-microbial, –anti-inflammatory– immunomodulatory,

is one of the most important proteins present in mammalian milk.

Page 55: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Bovine Lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.

• INTERVENTION: Infants were randomly assigned to receive orally administered Bovine Lactoferrin (BLF) (100 mg/d) alone (n = 153), BLF plus Lactobacillus GG (6 x 10(9) colony-forming units/d) (n = 151), or placebo (n = 168) from birth until day 30 of life (day 45 for neonates <1000 g at birth).

Manzoni et al JAMA. 2009; 302:1421-8.

Page 56: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Bovine Lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a

randomized trial.

• MAIN OUTCOME MEASURE: • First episode of late-onset sepsis, ie,

sepsis occurring more than 72 hours after birth with isolation of any pathogen from blood or from peritoneal or cerebrospinal fluid.

Manzoni et al JAMA. 2009; 302:1421-8.

Page 57: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Results :

LactoFerrin+LactobacillusGG vs. PLACEBOLF + LGG

(n=137)PLACEBO (n=153)

R.R. 95% C.I.

p-value

Late-Onset sepsis (all agents)

11/137(8.0%)

37/153(24.2%)

0.23 0.13-0.56

0.001

Total IFI (%) 3/137(2.2%)

12/153(7.8%)

0.33 0.08-0.78

0.02

NEC 0/137(0%)

10/153(6.5%)

0.11 0.18-0.54

0.002

Overall Mortality

6/137(4.4%)

13/153(8.5%)

0.41 0.08-1.09

0.09

Page 58: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

LF combinedn =(139+137) = 276

PLACEBO n = 153

R.R. 95% C.I.

p-value

Late-Onset sepsis (all agents)

23/276(8.3%)

37/153(24.2%)

0.28 0.16-0.50

<0.001

LOS by Gram-Positive 1.8% 7.8% 0.21 0.07-0.62 0.002

LOS by Gram-Negative 5.4% 10.5% 0.48 0.35-0.98 0.05

LOS by Candida spp 1.8% 7.8% 0.21 0.07-0.62 0.002

NEC 2/276(0.7%)

10/153(6.5%)

0.10 0.02-0.48 <0.001

Mortality (all causes prior to discharge)

3.3% 8.5% 0.36 0.15-0.87

0.02

Death OR NEC 4.7% 12.4% 0.34 0.16-0.72

0.004

RESULTS : LF combined (alone or with LGG) vs. PLACEBO

Power calculations: 0.95 for LOS, 0.74 for NEC, 0.65 for IFI, 0.45 for mortality

Page 59: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Bovine Lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.

• CONCLUSION: • Compared with placebo, Bovine

Lactoferrin supplementation alone or in combination with Lactobacillus rhamnosus GG (LGG) reduced the incidence of a first episode of late-onset sepsis in VLBW neonates.

Manzoni et al JAMA. 2009; 302:1421-8.

Page 60: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric
Page 61: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

NEURO-DEVELOPMENTAL OUTCOME

• “Long term neuro-developmental consequences of extreme prematurity are mediated not only by acute destructive events but also by disruptive effects on subsequent brain development in regions adjacent to and remote from the original injury.”

• Volpe JJ Lancet Neurol 2009;8;110-124

Page 62: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

CEREBELLAR INJURY

• Cerebellar injury is a previously under recognized form of prematurity related brain injury

• Cerebellar injury in the preterm infant is associated with impaired growth of the uninjured contralateral cerebral hemisphere with significant impairment evident as early as term equivalent

Page 63: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

CEREBELLAR INJURY (CI)

• Limperopolous measured volumes of cortical and subcortical gray matter and white matter in 38 preterm infants with MRI evidence of cerebellar injury.

• Unilateral CI was associated with significantly smaller volumes of cortical gray and cerebral white matter incontralateral cerebral hemisphere.

• Limperopoulos Pediatr Res 68;145-150,2010

Page 64: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

CEREBELLAR INJURY (CI)

• Regions affected were dorso-lateral prefrontal, premotor, sensorimotor and mid temporal regions.

• With bilateral CI –no significant inter hemispheric differences

• Hence regional cerebral growth impairment results from interruption of cerebrocerebral connectivity and loss of neuronal activation critical for development

• Limperopoulos Pediatr Res 68;145-150,2010

Page 65: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric
Page 66: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

COOLING BLANKET FOR HIE

Page 67: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Epidemiology of Perinatal Asphyxia

• Of ~ 130 million annual births world-wide, 4 million have evidence of birth asphyxia (30 per thousand). Of these 1 million die and 1 million develop neurologic sequelae.

Page 68: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

BIRTH ASPHXIA -HIE

• HIE is one of the leading causes of neurocognitive and motor delay in the pediatric age.– HIE moderate:

• 10% die• 30% neurocognitive/motor delay

– HIE severe: • 60% die • ~100% neurocognitive/motor delay

• No substantial changes in medical approach for decades.

Page 69: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Epidemiology of Perinatal Asphyxia

• Although the incidence of birth asphyxia is lower in the Western world, the annual rate is still high (3-6 per thousand term births).

• Over the past 20 years, the incidence of birth asphyxia has remained constant, despite major advances in perinatal medicine

Page 70: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Mechanism of Action of Hypothermia

• Reduces cerebral metabolism• Prevents cerebral edema• Preserves ATP levels; decreases energy

utilization• Reduces/suppresses cytotoxic AA accumulation• Reduces NO synthase activity• Suppresses free radical activity• Inhibits apoptosis [cell death]• Prolongs therapeutic window? Shankaran

Page 71: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

ENCEPHALOPATHY ENROLLMENT CRITERIA FOR HYPOTHERMIA TRIALS

• A hypoxic-ischemic insult occurring around the time of birth resulting in an encephalopathic state characterized by the need for resuscitation at birth, severe metabolic acidosis, neurological depression, seizures and electroencephalographic abnormalities.

• Enrollment within 6 hours

Page 72: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Induced HypothermiaDeath/Severe Neuromotor Disability

0%

10%

20%

30%

40%

50%

60%

70%

CoolCap* NICHD**

Treated

Control

56%57%

39%46%

*RR 0.81 [0.62, 1.05], p=0.10; **RR 0.72 [0.52, 0.95], p=0.02

Page 73: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Edwards, A D. et al. BMJ 2010;340:c363

Therapeutic hypothermia compared with normothermia

death or disability ("events").

Page 74: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Edwards, A D. et al. BMJ 2010;340:c363

Therapeutic hypothermia compared with normothermiaNormal Neurologic Function ("events").

Page 75: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Edwards, A D. et al. BMJ 2010;340:c363

Therapeutic hypothermia compared with normothermiaMortality ("events").

Page 76: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Edwards, A D. et al. BMJ 2010;340:c363

Therapeutic hypothermia compared with normothermiaDeath or Disability stratified by severity of encephalopathy

("events").

Page 77: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

CURRENT STATUS HYPOTHERMIA

WBH/SHC are relatively safe– Reduce mortality due to HIE.

–Increase intact survival at 2 years of age.

–Number needed to treat (NNT) of 6-8.

Page 78: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Cilio MR, Ferriero DM Synergistic neuroprotective therapies with hypothermia.

Semin Fetal Neonatal Med;2010;15;293

• Neuroprotection is a major health care priority, given the enormous burden of human suffering and financial cost caused by perinatal brain damage.

• With hypothermia as therapy for term HIE, there is hope for repair and protection of the brain after a profound neonatal insult.

• However, it is clear from the published clinical trials and animal studies that hypothermia alone will not provide complete protection or stimulate the repair that is necessary for normal neuro developmental outcome.

Page 79: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Cilio MR, Ferriero DM Synergistic neuroprotective therapies with hypothermia.

Semin Fetal Neonatal Med;2010;15;293

• Possible adjunctive and synergistic therapies with hypothermia include xenon, N-acetylcysteine, erythropoietin, melatonin and cannabinoids in addition to anti-convulsive therapy.

Page 80: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Morriss, F. H. Neoreviews 208;9:e8-e23

Copyright ©2008 American Academy of Pediatrics

Factors contributing to medical errors and the pathway from error to adverse medical event in the neonatal intensive care unit

Page 81: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

What Should We Do ?

Page 82: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

What Should We Do ?

Ann Intern Med 2010; 153:213-221

Page 83: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric

Thomas & Zoe Quaid

Page 84: Recent Advances in Neonatology Jonathan Fanaroff, MD, JD Assistant Professor of Pediatrics Case School of Medicine Director Rainbow Center for Pediatric